SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.68-2.4%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (14109)11/15/2004 9:10:54 AM
From: James Eccles  Read Replies (1) of 52153
 
MSITF actually has more like 1.9 billion as pre last stock holder meeting but they also are currently selling their rapid test kits to 19+ countries with china due in any time.

what do you think they could get to? kerryassociates.com estimates 5-10 cents when china approval comes but that report was before they started recieving and shipping to russia,japan,vietnam,congo,india,ect. not to mention that china gov. approved preshipping kits in anticipation of approval,also company estimates demand in the millions for most if not all the countries so far mentioned

on top of all that they passed US FDA testing with 100% accuracy,sensitivety,and specificity atleast so far as the live testing goes .

if you could give any help as to best case senerio how much could this be worth i can not imagine 5-10 cents once china get approved as being an accurate estimate .

orasure trades for 7$ and some change and they only have one test on the market for hiv

MSITF has 5 tests on the market for Teberculiosis,hiv,menaupause,dengue fever,hepatitus b&c,and west nile virus

so back to where we started how much $$ could they make???
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext